MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Clinical trials for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New treatment hope for rare kidney disease patients
Disease control APPROVED_FOR_MARKETINGThis program provides early access to pegcetacoplan for people with rare kidney diseases called C3 glomerulopathy (C3G) or primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN). The treatment is for patients aged 12 and older who have active kidney disease and…
Matched conditions: MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
European team hunts for better tests to spot rare kidney disease
Diagnosis OngoingThis study aims to create better tests to diagnose and monitor two rare, serious kidney diseases (aHUS and C3G). Researchers will analyze blood, cells, and tissue from about 180 patients and healthy people to find new markers of disease. The goal is to help doctors make faster, m…
Matched conditions: MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC